Ligand validation:4BTX

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4BTX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BTX_NAG_A_1768	40%	29%	0.16	0.87	0.88	1.93	-	5	1	0	100%	0.9333
4BTX_NAG_B_1769	31%	45%	0.177	0.847	0.59	1.5	-	3	2	0	100%	0.9333
4BTX_NAG_B_1771	6%	17%	0.27	0.706	0.85	2.71	-	7	0	0	100%	0.9333
4BTX_NAG_A_1772	2%	55%	0.352	0.625	0.46	1.26	-	2	0	0	93%	0.9333
4BTX_NAG_B_1773	1%	50%	0.419	0.598	0.59	1.33	-	2	0	0	100%	0.9333
4BTX_NAG_A_1770	1%	10%	0.506	0.662	0.83	3.45	-	6	0	0	100%	0.9333
4BTX_NAG_B_1772	1%	27%	0.545	0.623	0.85	2.08	1	4	0	0	100%	0.9333
2C11_NAG_A_1734	100%	66%	0.027	0.989	0.67	0.63	-	-	4	0	100%	0.9333
2C10_NAG_D_1770	38%	47%	0.175	0.876	0.68	1.33	-	2	0	0	100%	0.9333
4BTY_NAG_A_1767	32%	23%	0.195	0.869	0.83	2.28	-	7	0	0	100%	0.9333
3ALA_NAG_D_1775	25%	33%	0.192	0.824	0.69	1.93	-	4	0	0	100%	0.9333
1PU4_NAG_B_2781	23%	32%	0.273	0.897	0.98	1.68	1	5	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.